Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.69 |
| ▸ | TSHR | P16473 | 7/20 | 0.69 |
| ▸ | LMNA | P02545 | 2/20 | 0.69 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.66 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.66 |
| ▸ | TP53 | P04637 | 1/20 | 0.66 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.62 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8987694 | 0.92 | ALDH1A1 (0.84) | ALDH1A1TSHRLMNACYP3A4MAPK1 | |
| SCHEMBL7759350 | 0.88 | TSHR (0.83) | ALDH1A1TSHRLMNACYP3A4MAPK1 | |
| SCHEMBL11655445 | 0.85 | ALDH1A1 (0.69) | ALDH1A1TSHRLMNACYP3A4MAPK1 | |
| SCHEMBL28188145 | 0.83 | ALDH1A1 (0.71) | ALDH1A1TSHRLMNACYP3A4MAPK1 | |
| SCHEMBL21143371 | 0.83 | ALDH1A1 (0.71) | ALDH1A1TSHRLMNACYP3A4MAPK1 | |
| SCHEMBL1813573 | 0.83 | ALDH1A1 (0.71) | ALDH1A1TSHRLMNACYP3A4MAPK1 | |
| SCHEMBL1395556 | 0.83 | ALDH1A1 (0.71) | ALDH1A1TSHRLMNACYP3A4MAPK1 | |
| SCHEMBL684368 | 0.83 | ALDH1A1 (0.71) | ALDH1A1TSHRLMNACYP3A4MAPK1 | |
| SCHEMBL11653034 | 0.83 | TSHR (0.68) | ALDH1A1TSHRLMNACYP3A4MAPK1 | |
| SCHEMBL9694057 | 0.83 | ALDH1A1 (0.87) | ALDH1A1TSHRLMNACYP3A4MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8507612-B2 | Aziridine crosslinking agents for acrylic adhesives | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2013-08-13 | — | — | US | disclosed |
| EP-2406338-B1 | AZIRIDINE CROSSLINKING AGENTS FOR ACRYLIC ADHESIVES | 3M INNOVATIVE PROPERTIES CO (US) | 2012-11-28 | — | — | EP | disclosed |
| EP-2406338-A1 | AZIRIDINE CROSSLINKING AGENTS FOR ACRYLIC ADHESIVES | 3M Innovative Properties Company (US) | 2012-01-18 | — | — | EP | disclosed |
| WO-2010104645-A1 | AZIRIDINE CROSSLINKING AGENTS FOR ACRYLIC ADHESIVES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2010-09-16 | — | — | WO | disclosed |
| US-20100227969-A1 | AZIRIDINE CROSSLINKING AGENTS FOR ACRYLIC ADHESIVES | 3M INNOVATIVE PROPERTIES COMPANY | 2010-09-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100227969-A1 | AZIRIDINE CROSSLINKING AGENTS FOR ACRYLIC ADHESIVES | AAAS, ADGRF1, CDH1 | ALDH1A1 401/4885TSHR 4515/4885LMNA 1936/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.